Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1469 of 5804
-
New combo shrinks liver tumors in hard-to-treat colorectal cancer
Disease control CompletedThis study was a phase 2, single-arm, single-center clinical trial in which previously treated patients with unresectable colorectal cancer liver metastases.
Phase: PHASE2 • Sponsor: Meng Qiu • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New balloon treatment for clogged arteries shows promise
Disease control CompletedThis Clinical Evaluation Report (CER) covers the Mamba Sirolimus-Eluting PTCA Balloon catheter intended for the treatment of coronary artery disease in de novo or in-stent restenosis lesions. It includes analysis of clinical data from the MIRAGE clinical study, literature data on…
Phase: PHASE4 • Sponsor: Frisch Medical Device Private Limited • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New hope for tough breast cancer: experimental drug EP0062 enters human trials
Disease control Recruiting nowThe aim of this study is to identify the optimal dose for EP0062 as monotherapy and in combination with standard-of-care therapies to assess its Safety, Tolerability, Pharmacokinetics, and Efficacy in Patients with Relapsed Locally Advanced or Metastatic AR+/HER-2-/ER+ Breast Can…
Phase: PHASE1, PHASE2 • Sponsor: Ellipses Pharma • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New Antibody-Drug conjugate takes aim at Hard-to-Treat gynaecological cancers
Disease control OngoingIIMGN151-1001 is a Phase 1, first in human, open-label dose-escalation, optimization, and expansion study designed to characterize the safety, tolerability, pharmacokinetics (PK), immunogenicity, and preliminary antitumor activity of IMGN151 in adult participants with recurrent e…
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Simple blood and tissue tests could revolutionize lung cancer care
Diagnosis Recruiting nowThis study is an observational study of blood and tissue biomarkers. Investigators plan to evaluate the accuracy of lung cancer biomarkers found in the blood in determining if a lung nodule is cancer or benign. Investigators also plan to examine another biomarker found in the tum…
Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Diagnosis
Last updated Jun 27, 2026 12:01 UTC
-
Can a common drug stop dangerous bleeding in pregnancy?
Disease control CompletedAbruptio placenta is one of the common causes of antepartum haemorrhage which is more common in the second half of pregnancy and causes a high maternal and neonatal morbidity and mortality
Phase: NA • Sponsor: Hawler Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Virus cocktail inhaled to fight Drug-Resistant lung infection
Disease control CompletedA phase 2, multi-center, double-blind, randomized, placebo-controlled study to evaluate the safety, phage kinetics, and efficacy of inhaled AP-PA02 administered in subjects with non-cystic fibrosis bronchiectasis and chronic pulmonary Pseudomonas aeruginosa infection.
Phase: PHASE2 • Sponsor: Armata Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New triple-threat approach targets deadly mesothelioma in early trial
Disease control Recruiting nowThe study is a single-arm phase I trial to evaluate the safety, feasibility, and preliminary efficacy of the addition of pembrolizumab and image-guided resection to surgical therapy and chemotherapy for malignant pleural mesothelioma (MPM).
Phase: PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Malaria vaccine trial targets kids with HIV
Disease control CompletedA Phase Ib trial to evaluate the safety and immunogenicity of R21/Matrix-M™ in African children living with HIV
Phase: PHASE1 • Sponsor: University of Oxford • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New depression drug shows promise in Mid-Stage trial
Symptom relief CompletedThe purpose of this study is to determine efficacy differences between ALTO-100 and placebo, used either as monotherapy or adjunctively to an antidepressant, related to patient characteristics.
Phase: PHASE2 • Sponsor: Alto Neuroscience • Aim: Symptom relief
Last updated Jun 26, 2026 14:27 UTC
-
New study tests smartphone app to fight chemo nerve damage
Symptom relief Recruiting nowThis is a prospective randomized trial designed to investigate a new care model for patients who suffer from nerve damage from chemotherapy called chemotherapy induced peripheral neuropathy (CIPN). All participants in the study will report their CIPN symptoms daily using a websit…
Phase: NA • Sponsor: University of Vermont • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Can a smartphone program steer young adults away from heavy drinking by boosting rewarding, alcohol-free activities?
Disease control OngoingEmerging adult risky drinkers living in disadvantaged communities often have limited access to rewarding activities and adult roles that offer alternatives to heavy drinking. Guided by behavioral economics, this cluster randomized controlled trial will evaluate a brief behavioral…
Phase: NA • Sponsor: University of Florida • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New eye injection shows promise for blurry vision from uveitis
Disease control CompletedThis study will assess the efficacy and safety of vamikibart in participants with uveitic macular edema.
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Experimental cocktail aims to turn tumors against themselves
Disease control OngoingThis phase I trial evaluates the safety and effectiveness of in situ immunomodulation with CDX-301, radiotherapy, CDX-1140 and Poly-ICLC (Cohort A) and these with intravenous (IV) pembrolizumab and subcutaneous (SC) tocilizumab (Cohort B) in treating patients with unresectable an…
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New dosing strategy may boost ovulation in PCOS-Related infertility
Disease control CompletedThe goal of this clinical trial is to learn if drug letrozole in step up dose works better to treat anovulation in infertile women with polycystic ovary syndrome. It will also learn about the safety of drug letrozole in step up dose. The main Questions it aims to answer are: * D…
Phase: PHASE3 • Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
No-Radiation breast scanner could change cancer detection
Diagnosis Recruiting nowThis is a multicentric, single arm, prospective, stratified by breast density clinical investigation to confirm the ability of the microwave mammogram 'MammoWave' to detect breast lesions. MammoWave is a innovative medical device, class IIa marked CE, which uses microwaves inste…
Phase: NA • Sponsor: Umbria Bioengineering Technologies • Aim: Diagnosis
Last updated Jun 27, 2026 12:34 UTC
-
Can Lab-Grown tumors stop breast cancer from coming back?
Knowledge-focused Recruiting nowThis is a prospective phase 2 study to use Functional Precision Oncology (FPO) to predict, prevent and treat early metastatic recurrence in subjects with HR-low/Her2 negative or triple negative breast cancer.
Phase: PHASE2 • Sponsor: University of Utah • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
New combo therapy aims to boost immunotherapy in Hard-to-Treat cancers
Disease control OngoingThis study is a multicenter, open-label, proof-of-concept study aiming to assess the clinical and biological impact of NP137 when added to standard PD-1/PD-L1 blockade therapy in 3 independent cohorts of advanced or metastatic solid tumors with various sensitivity to anti-PD-1/PD…
Phase: PHASE2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a sleep drug boost metabolic health in menopausal women?
Symptom relief CompletedThe aim of this study is to determine if suvorexant can help treat the severity of insomnia and improve metabolic health in midlife women who had both insomnia and indicators of metabolic syndrome.
Phase: PHASE4 • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Engineered immune cells take on viruses in cancer patients
Disease control Recruiting nowThis phase I trial tests the feasibility and safety of genetically modified cytotoxic T-lymphocytes in controlling infections caused by adenovirus (ADV), BK virus (BKV), cytomegalovirus (CMV), JC virus (JCV), or COVID-19 in immunocompromised patients with cancer. Viral infections…
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC